Advertisement

Breast Cancer Research and Treatment

, Volume 14, Issue 3, pp 349–353 | Cite as

Tissue ferritin concentration and prognosis in carcinoma of the breast

  • Robert E. Weinstein
  • Bernice H. Bond
  • Boris K. Silberberg
  • Clarence B. Vaughn
  • Perla Subbaiah
  • David R. Pieper
Report

Summary

Seven year follow-up data were available on 36 of 40 breast carcinoma patients in whom breast tissue ferritin concentrations at the time of surgery were known. 18 patients were alive and free of recurrence or second tumor (Group 1) and 11 died with breast cancer (Group 2). Patients with lower tissue ferritin concentrations defined as < 319 ng/mcp (nanograms of ferritin/milligram of cytosol protein) were at reduced risk: 86% of patients with low tissue ferritin concentration survived free of recurrence or second tumor vs. 40% of patients with high tissue ferritin concentration (P = 0.0056). Mean breast carcinoma tissue ferritin concentration was 295 ± 52 ng/mcp in Group 1 and 444 ± 55 ng/mcp in Group 2 (P = 0.036).

Lymph node involvement was predictive of mortality from breast carcinoma (P = 0.0003), but did not correlate with mean tissue ferritin concentration (P = 0.082). 10/10 (100%) patients who had both low tissue ferritin concentration and absence of lymph node involvement were in Group 1.

The correlation of breast tissue ferritin concentration with histopathologic dedifferentiation and with prognosis suggests tumor tissue ferritin as a marker of malignant potential.

Key words

ferritin nodal status prognostic factors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jacobs A, Miller F, Worwood M, Beamish MR, Wardrop CA: Ferritin in the serum of normal subjects and patients with iron deficiency and iron overload. Br Med J 4: 206–208, 1972PubMedGoogle Scholar
  2. 2.
    Lipschitz DA, Cook JD, Finch CA: Clinical evaluation of serum ferritin as an index of iron stores. N Engl J Med 290: 1213, 1974PubMedGoogle Scholar
  3. 3.
    Prieto J, Barry M, Sherlock S: Serum ferritin in patients with iron overload and with acute and chronic liver diseases. Gastroenterology 68: 525–533, 1975PubMedGoogle Scholar
  4. 4.
    Jacobs A, Worwood M: Ferritin in serum: Clinical and biochemical implications. N Engl J Med 292: 951–956, 1975PubMedGoogle Scholar
  5. 5.
    Drysdale JW: Iron Metabolism, Ciba Foundation Symposium 51 (New Series). Elsevier/Excerpta Medica/North Holland, Amsterdam, 1977, pp 41–57Google Scholar
  6. 6.
    White GP, Worwood M, Parry DH, Jacobs A: Ferritin synthesis in normal and leukemic leukocytes. Nature 250: 584–586, 1974PubMedGoogle Scholar
  7. 7.
    Parry DH, Worwood M, Jacobs A: Ferritin in acute leukemia at presentation and during remission. Br Med J 1: 245–247, 1975PubMedGoogle Scholar
  8. 8.
    Jones PAE, Miller FM, Worwood M, Jacobs A: Ferritinaemia in leukemia and Hodgkins disease. Br J Cancer 27: 212–217, 1973PubMedGoogle Scholar
  9. 9.
    Sarcione EJ, Smalley JR, Lema MJ, Stutzman L: Increased ferritin synthesis and release by Hodgkin's disease peripheral blood lymphocytes. Int J Cancer 20: 339–346, 1977PubMedGoogle Scholar
  10. 10.
    Hazard JT, Drysdale JW: Ferritinaemia in cancer. Nature 265: 755–756, 1977PubMedGoogle Scholar
  11. 11.
    Kew MC, Torrance JD, Derman D, Simon M, Macnab GM, Charlton RW, et al: Serum and tumor ferritins in primary liver cancer. Gut 19: 294–299, 1978PubMedGoogle Scholar
  12. 12.
    Marcus DM, Zinberg N: Isolation of ferritin from human mammary and pancreatic carcinomas by means of antibody immunoadsorbents. Arch Biochem Biophys 162: 493–501, 1974PubMedGoogle Scholar
  13. 13.
    Jacobs A, Jones B, Ricketts C, Bulbrook RD, Wang DY: Serum ferritin concentration in early breast cancer. Br J Cancer 34: 286–290, 1976PubMedGoogle Scholar
  14. 14.
    Marcus DM, Zinberg N: Measurement of serum ferritin by radioimmunoassay: results in normal individuals and patients with breast cancer. J Natl Cancer Inst 55: 791–795, 1975PubMedGoogle Scholar
  15. 15.
    Coombes RC, Powles TJ, Gazet JC, Ford HT, Nash AG, Sloane JP, et al: A biochemical approach to the staging of breast cancer. Cancer 40: 937–944, 1977PubMedGoogle Scholar
  16. 16.
    Bezwoda W, Derman D, Bothwell T, MacPhail P, Levin J, De Moor N: Significance of serum ferritin concentration of carcinoembryonic antigen, ferritin, and calcitonin in breast cancer. Cancer 48: 1623–1628, 1981PubMedGoogle Scholar
  17. 17.
    Weinstein RE, Bond BH, Silberberg BK: Tissue ferritin concentration in carcinoma of the breast. Cancer 50: 2406–2409, 1982PubMedGoogle Scholar
  18. 18.
    Chen YM, Vaughn CB: Studies on the endogenous activation and inhibition of hormone receptor reaction. Anticancer Res 4: 2773–278, 1984Google Scholar
  19. 19.
    McGuire WL: Adjuvant therapy of node-negative breast cancer (editorial). N Engl J Med 320: 525–526, 1989PubMedGoogle Scholar
  20. 20.
    Stewart JF, Rubens RD: In: Bonadonna (ed) Breast Cancer: Diagnosis and Management. John Wiley & Sons, Chichester, 1984, pp 141–167Google Scholar
  21. 21.
    Gion M, Mione R, Dittadi R, Fasan S, Pallini A, Bruscagnin G: Carcinoembrionic antigen, ferritin, and tissue polypeptide antigen in serum and tissue: Relationship with the receptor content in breast carcinoma. Cancer 57: 917–922, 1986PubMedGoogle Scholar
  22. 22.
    Tappin JA, George WB, Bellingham AJ: Effect of surgery on serum ferritin concentration in patients with breast cancer. Br J Cancer 40: 658–660, 1979PubMedGoogle Scholar
  23. 23.
    Watanabe N, Niitsu Y, Koseki J, Oikawa J, Yukata K, Ishii T, et al: Ferritinemia in nude mice bearing various human carcinomas. In: Lehmann FG (ed) Carcino-embryonic Proteins: vol 1. Elsevier/North-Holland Biomedical Press, Amsterdam, 1979, pp 273–278Google Scholar
  24. 24.
    Hann HL, Stahlhut MW, Millman I: Human ferritins present in the sera of nude mice transplanted with human neuroblastoma or hepatocellular carcinoma. Cancer Research 44: 3898–3901, 1984PubMedGoogle Scholar
  25. 25.
    Klein JL, Kopher KA, Rostock RA: Ferritin concentration and131I-antiferritin tumor localization in an experimental hepatoma. Int J Radiat Oncol Biol Phys 12: 137–140, 1986PubMedGoogle Scholar
  26. 26.
    Koopmans LH: Introduction to Contemporary Statistical Methods. Duxbury Press, Boston, 1987Google Scholar
  27. 27.
    Lopez-Karpovitch X, Piedras J, Sosa A, Alvarez-Hernandez X, Cano R, Gomez-Almaguer D, Cordova MS: Ferritin and malignant hemopathies. II. Serum ferritin in adults with acute lymphocytic leukemia at presentation and in remission. Rev Invest Clin 35: 225–229, 1983PubMedGoogle Scholar
  28. 28.
    Hann HL, Evans AE, Cohen IJ, Leitmeyer JE: Biologic differences between neuroblastoma Stages IV-S and IV. N Engl J Med 305: 425–429, 1981PubMedGoogle Scholar
  29. 29.
    Linkesch W, Ludwig H: Serum ferritin and B2-microglobulinemia in patients with multiple myeloma. Cancer Detection and Prevention 6: 297–301, 1983PubMedGoogle Scholar
  30. 30.
    Volpino P, Cangemi V, Caputo V, Mazzarino E, Galati G: Clinical usefulness of serum ferritin measurements in lung cancer. J Nucl Med Allied Sci 28: 27–30, 1984PubMedGoogle Scholar
  31. 31.
    Ogier C, Giannoulis N, Jacobs A, Reizenstein PG: The use of serum ferritin to identify good and bad prognosis groups in acute myeloid leukemia. Haematologica 69: 111–112, 1984PubMedGoogle Scholar
  32. 32.
    Dorner MH, Abel U, Fritze D, Manke H, Drings P: Serum ferritin in relation to the course of Hodgkin's disease. Cancer 52: 2308–2312, 1983PubMedGoogle Scholar
  33. 33.
    Mufti GJ, Hamblin TJ, Stevens J: Basic isoferritin and hypercalcemia in renal cell carcinoma. J Clin Pathol 35: 1008–1010, 1982PubMedGoogle Scholar
  34. 34.
    Cairo G, Vezzoni P, Bardella L, Schiaffonati L, Rappocciolo E, Levi S, Arosio P, Bernelli-Zazzera A: Regulation of ferritin synthesis in malignant and non-malignant lymphoid cells. Biochem Biophys Res Commun 139: 652–657, 1986PubMedGoogle Scholar
  35. 35.
    Cazzola M, Arosio P, Belloti V, Bergamaschi G, Dezza L, Iacobello C, et al: Immunological reactivity of serum ferritin in patients with malignancy. Tumori 71: 547–554, 1985PubMedGoogle Scholar
  36. 36.
    Ramot B, Biniaminov M, Shoham CH, Rosenthal E: Effect of levamisole on E-rosette forming cells in vivo and in vitro in Hodgkin's disease. N Engl J Med 294: 809–811, 1976PubMedGoogle Scholar
  37. 37.
    Moroz C, Lahat N, Biniaminov M, Ramot B: Ferritin on the surface of lymphocytes in Hodgkin's disease patients: A possible blocking substance removed by levamisole. Clin Exp Immunol 29: 30–35, 1977PubMedGoogle Scholar
  38. 38.
    Moroz C, Giler S, Kupfer B, Urca I: Lymphocytes bearing surface ferritin in patients with Hodgkin's disease and breast cancer. N Engl J Med 296: 1172–1173, 1977Google Scholar
  39. 39.
    Moroz C, Kan M, Chaimof C, Marcus H, Kupfer B, Cuckle HS: Ferritin-bearing lymphocytes in the diagnosis of breast cancer. Cancer 54: 84–89, 1984PubMedGoogle Scholar
  40. 40.
    Moroz C, Kupfer B: Supressor cell activity of ferritin-bearing lymphocytes in patients with breast cancer. Isr J Med Sci 17: 879–881, 1981PubMedGoogle Scholar
  41. 41.
    Matzner Y, Hershko C, Polliack A, Konijn AM, Izak G: Supressive effect of ferritin on in-vitro lymphocyte function. Br J Hematol 42: 345–353, 1979Google Scholar
  42. 42.
    Matzner Y, Konijn AM, Shlomai Z, Ben-Basset H: Different effect of isolated placental isoferritins on in vitro Tlymphocyte function. Br Med J Haematology 59: 443–448, 1985Google Scholar
  43. 43.
    Bluestein BI, Luderer AA, Hess D, Smith D, Meyer KK, Boyel G, Carter AC: Measurement of ferritin-bearing peripheral mononuclear blood cells in cancer patients by radioimmunoassay. Cancer Research 44: 4131–4136, 1984PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Robert E. Weinstein
    • 1
  • Bernice H. Bond
    • 2
  • Boris K. Silberberg
    • 3
  • Clarence B. Vaughn
    • 1
  • Perla Subbaiah
    • 4
  • David R. Pieper
    • 5
  1. 1.From Providence Hospital, Department of MedicineSouthfieldUSA
  2. 2.Department of ImmunopathologyHenry Ford HospitalDetroitUSA
  3. 3.Department of PathologySouthfieldUSA
  4. 4.Department of Mathematic SciencesOakland UniversityRochesterUSA
  5. 5.Department of PhysiologySouthfieldUSA

Personalised recommendations